Year: 2002
Type: review
Abstract: onalcoholic steatohepatitis (NASH) is a clinicopathologic condition often seen in obese, diabetic women in the absence of significant alcohol use (Ͻ20 g/d for women and Ͻ30 g/d for men) and hepatic histology consistent with alcoholic hepatitis.[1][2][3][4][5] NASH is part of a larger spectrum of conditions comprising nonalcoholic fatty liver (NAFL) that also includes hepatic steatosis alone and hepatic steatosis with nonspecific inflammation.This distinction is important because NASH can result in progressive liver disease while the other forms of NAFL may not.6 The histopathologic criteria for NASH are currently being defined, but generally include the presence of hepatic steatosis and lobular inflammation with any one of the following histopathologic features in zone 3 hepatocytes: (1) ballooning degeneration, (2) sinusoidal fibrosis, or (3) Mallory hyaline.[6][7][8][9] This review summarizes the epidemiologic impact of NAFL, risk factors and determinants of severity of NAFL, the theories of pathogenesis of NASH, and treatment options.
Source: Hepatology
Institutions: Inova Fairfax Hospital, Johns Hopkins University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2049416794
